103 related articles for article (PubMed ID: 8584609)
41. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G
Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
[TBL] [Abstract][Full Text] [Related]
42. Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects.
Anderson MS; Gilmartin J; Cilissen C; De Lepeleire I; Van Bortel L; Dockendorf MF; Tetteh E; Ancona JK; Liu R; Guo Y; Wagner JA; Butterton JR
Antivir Ther; 2015; 20(4):397-405. PubMed ID: 25470746
[TBL] [Abstract][Full Text] [Related]
43. Dihydrexidine produces hypothermia in rats via activation of dopamine D1 receptors.
Salmi P; Ahlenius S
Neurosci Lett; 1997 Oct; 236(1):57-9. PubMed ID: 9404951
[TBL] [Abstract][Full Text] [Related]
44. The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men.
Agersø H; Jensen LB; Elbrønd B; Rolan P; Zdravkovic M
Diabetologia; 2002 Feb; 45(2):195-202. PubMed ID: 11935150
[TBL] [Abstract][Full Text] [Related]
45. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma.
Fowler A; Koenen R; Hilbert J; Blatchford J; Kappeler D; Benediktus E; Wood C; Gupta A
J Clin Pharmacol; 2017 Nov; 57(11):1444-1453. PubMed ID: 28609567
[TBL] [Abstract][Full Text] [Related]
46. Further evidence for clozapine as a dopamine D1 receptor agonist.
Salmi P; Ahlenius S
Eur J Pharmacol; 1996 Jun; 307(1):27-31. PubMed ID: 8831100
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
[TBL] [Abstract][Full Text] [Related]
48. Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans.
Rosenberg G; Angel I; Kozak A
Br J Clin Pharmacol; 2005 Jul; 60(1):7-16. PubMed ID: 15963088
[TBL] [Abstract][Full Text] [Related]
49. Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans.
Reece PA; Sedman AJ; Rose S; Wright DS; Dawkins R; Rajagopalan R
J Clin Pharmacol; 1994 Nov; 34(11):1126-32. PubMed ID: 7876406
[TBL] [Abstract][Full Text] [Related]
50. Single oral dose safety, tolerability, and pharmacokinetics of PNU-96391 in healthy volunteers.
Rodríguez CA; Azie NE; Adams G; Donaldson K; Francom SF; Staton BA; Bombardt PA
J Clin Pharmacol; 2004 Mar; 44(3):276-83. PubMed ID: 14973308
[TBL] [Abstract][Full Text] [Related]
51. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.
Guo N; Hwang DR; Lo ES; Huang YY; Laruelle M; Abi-Dargham A
Neuropsychopharmacology; 2003 Sep; 28(9):1703-11. PubMed ID: 12813475
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics and pharmacodynamics of the ETA-selective endothelin receptor antagonist SPP301 in healthy human subjects.
Dieterle W; Mann J; Kutz K
J Clin Pharmacol; 2004 Jan; 44(1):59-66. PubMed ID: 14681342
[TBL] [Abstract][Full Text] [Related]
53. Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration.
Farré M; Roset PN; Llorente M; Márquez M; Albet C; Pérez JA; Herrero E; Ortíz JA
Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):343-50. PubMed ID: 9379783
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects.
Krösser S; Tillner J; Fluck M; Ungethüm W; Wolna P; Kovar A
Int J Clin Pharmacol Ther; 2007 May; 45(5):271-80. PubMed ID: 17542349
[TBL] [Abstract][Full Text] [Related]
55. [11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjects.
Slifstein M; Kegeles LS; Gonzales R; Frankle WG; Xu X; Laruelle M; Abi-Dargham A
J Cereb Blood Flow Metab; 2007 Oct; 27(10):1733-41. PubMed ID: 17311076
[TBL] [Abstract][Full Text] [Related]
56. Safety and pharmacokinetics of multiple doses of aclidinium bromide administered twice daily in healthy volunteers.
Lasseter K; Dilzer S; Jansat JM; Garcia Gil E; Caracta CF; Ortiz S
Pulm Pharmacol Ther; 2012 Apr; 25(2):193-9. PubMed ID: 22366196
[TBL] [Abstract][Full Text] [Related]
57. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
Chi YH; Lee H; Paik SH; Lee JH; Yoo BW; Kim JH; Tan HK; Kim SL
Am J Cardiovasc Drugs; 2011 Oct; 11(5):335-46. PubMed ID: 21910510
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics and safety of deramciclane during multiple oral dosing.
Kanerva H; Kilkku O; Helminen A; Rouru J; Scheinin M; Huupponen R; Klebovich I; Drabant S; Urtti A
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):589-97. PubMed ID: 10599951
[TBL] [Abstract][Full Text] [Related]
59. Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: a single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers.
Jung J; Choi S; Cho SH; Ghim JL; Hwang A; Kim U; Kim BS; Koguchi A; Miyoshi S; Okabe H; Bae KS; Lim HS
Clin Ther; 2010 Jun; 32(6):1178-87. PubMed ID: 20637970
[TBL] [Abstract][Full Text] [Related]
60. Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist.
Macdonald GJ; Branch CL; Hadley MS; Johnson CN; Nash DJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Austin NE; Jeffrey P; Winborn KY; Boyfield I; Hagan JJ; Middlemiss DN; Reavill C; Riley GJ; Watson JM; Wood M; Parker SG; Ashby CR
J Med Chem; 2003 Nov; 46(23):4952-64. PubMed ID: 14584946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
